First-Line Anti–PD-1 Immunotherapy With Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis by PD-1 Subtype

First-line anti-PD-1-based immunotherapy combinations significantly improve survival and response outcomes over sunitinib in advanced RCC, with consistent efficacy across PD-1 subtypes and PD-L1 expression groups.

Authors

Institutions

Publication Details

Journal
Urology Practice
Published
2025-12-24
DOI
https://doi.org/10.1097/upj.0000000000000963
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-Line Anti–PD-1 Immunotherapy With Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis by PD-1 Subtype

W. Ben kridis, Afef Khanfir
Urology Practice
Renal cell carcinoma treatment
article

First-Line Anti–PD-1 Immunotherapy With Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis by PD-1 Subtype

W. Ben kridis, Afef Khanfir
article en

Abstract

First-line anti-PD-1-based immunotherapy combinations significantly improve survival and response outcomes over sunitinib in advanced RCC, with consistent efficacy across PD-1 subtypes and PD-L1 expression groups.

Urology Practice
University of Sfax (TN), Hopital Universitaire Habib Bourguiba (TN)
Good health and well-being
Openalex Percentile: Top 28%
Renal cell carcinoma treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

First-Line Anti–PD-1 Immunotherapy With Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: A Meta-Analysis by PD-1 Subtype — W. Ben kridis, Afef Khanfir · Urology Practice (2025) | TGRS Research Map | TGRS